Price $238.49 |
Market Cap
66.3B
|
Sector Health Care |
Div. Growth
-100.00%
|
|
P/E
45.8
|
P/B
2.64
|
P/S
3.59
|
Dividend %
1.50%
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-
|
FCF
-
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-
|
ROI
5.20%
|
|
ROA
-
|
EPS Growth
-
|
Current Ratio
1.0
|
Debt/Equity
54.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Biomerica Inc (BMRA) | $2.26 | - | - | 37.5M | Strong Buy |
| LifeVantage Corp (LFVN) | $3.45 | - | 3.10% | 48.7M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $1.77 | - | - | 129.6M | Strong Buy |
| Anika Therapeutics Inc (ANIK) | $26.62 | - | - | 459.3M | Strong Buy |
| Sesen Bio Inc (SESN) | $0.63 | - | - | 118.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
